Non Invasive Prenatal Screening

Early Intervention, Healthy Babies!

NIPS is a non invasive test, performed on cfDNA that screens Ultrasound abnormalities and chromosomal abnormalities identified by other screening tests.


When is NIPS advisable ?
When is NIPS advisable ?

NIPS is advisable when -There are concerns about chromosome abnormalities in your pregnancy.


NIPS is advisable when 

  • Ultrasound abnormalities have been identified .
  • You have had earlier abnormal screening results for this pregnancy.
  • You, your partner, or a prior pregnancy or child were identified with a chromosome abnormality.
  • You have received inconclusive results from another fetal DNA screening test.

Screens for most common trisomies including Trisomy 21,18,13 and sex chromosome aneuploidies. It provides aneuploidy information of all the other remaining chromosomes.

Price: ₹21000.00
MaterniT21 Plus
MaterniT21 Plus

A wealth of information revealed in a simple blood test.

Price: ₹40000.00
MaterniT Genome
MaterniT Genome

Because every chromosome matters, we analyze them all to get Karyotype level details.

Price: ₹65000.00


MaterniT21 Plus (from Sequenom Labs, USA) MaterniT Genome (from Sequenom Labs, USA) NIPS for All Trisomies (Validated in India)
Trisomy 21 22 Chromosomes Trisomy/ Monosomy 22 Chromosomes Trisomy/ Monosomy
Trisomy 18 Select Microdeletions  
Trisomy 13 Sex Chromosome Aneuploidy  
Trisomy 16 Deletions or Duplications=7mb  
Trisomy 22 Unbalanced Translocations  
Select Microdeletions    
Sex Chromosome Aneuploidies    


Stepping into Motherhood ?

FREE Sample Collection

PAN India Logistics

Accurate Reporting

Fast TAT

Stringent QC

You Might also Like

MyFit Baby Plus
One Package, Complete Pregnancy Journey

One Package, Complete Pregnancy Journey learn more >

PND Karyotying with CytoPrime Microarray
Can be performed for AF,CVS or POC

Can be performed for AF,CVS or POC learn more >

PND QF-PCR with CytoSure Microarray
Can be performed for AF,CVS or POC

Can be performed for AF,CVS or POC learn more >